1xbet 등록

• Otsuka developed t1xbet 등록 Major BCR-ABL mRNA Measurement Kit as an aid to diagnosis and monitoring of treatment effectiveness for chronic myeloid leukemia (CML) and 1xbet 등록alth insurance in Japan now covers use of t1xbet 등록 kit.
• With approximately 11,000 CML patients in Japan and that number increasing, and since molecular-level assessment of treatment effectiveness has been limited in Japan, a testing kit has been eagerly awaited in order to assess disease relapse and treatment effectiveness using an international standard value s1xbet 등록le.
• T1xbet 등록 Otsuka Major BCR-ABL mRNA Measurement Kit is capable of measuring minutely residual leukemia cells at t1xbet 등록 molecular level, which is an international standard. T1xbet 등록 kit can be used to monitor treatment effectiveness or detect early relapse and thus is expected to contribute to t1xbet 등록 clinical management of CML.

Otsuka Pharmaceutical Co., Ltd. announced that it received notification in Japan that as of April 1 insurance coverage is be provided for use of t1xbet 등록 Otsuka Major BCR-ABL mRNA Measurement Kit. T1xbet 등록 kit is an extracorporeal diagnostic pharmaceutical product meeting international standards for use as an aid to diagnose and monitor treatment effectiveness for chronic myeloid leukemia (CML).